Viking Therapeutics Inc logo

Viking Therapeutics Inc

$ 4.26 +0.13 (+3.15%) 10:08 PM EST
P/E:
At Loss
P/B:
2.16
Market Cap:
$ 326.69M
Enterprise V:
$ 163.34M
Volume:
719.59K
Avg Vol (2M):
895.11K
Also Trade In:
Volume:
719.59K
Market Cap $:
326.69M
PE Ratio:
At Loss
Avg Vol (2-Month):
895.11K
Enterprise Value $:
163.34M
PB Ratio:
2.16
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Name Current Vs Industry Vs History
Cash-To-Debt 94.76
Equity-to-Asset 0.91
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 72.5
9-Day RSI 61.66
14-Day RSI 59.14
6-1 Month Momentum % 92.38
12-1 Month Momentum % -17.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.74
Quick Ratio 11.74
Cash Ratio 11.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.9

Financials (Next Earnings Date:2023-02-09 Est.)

VKTX's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:VKTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.81
Beta 1.13
Volatility % 73.64
14-Day RSI 59.14
14-Day ATR ($) 0.23589
20-Day SMA ($) 4.144
12-1 Month Momentum % -17.34
52-Week Range ($) 2.02 - 5.32
Shares Outstanding (Mil) 76.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Viking Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Viking Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.